Timothy A. Springer - Director, 10%+ Owner at Cartesian Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
RNAC on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Timothy A. Springer - trading volume in the past year for Cartesian Therapeutics, Inc.

Holdings reported by Timothy A. Springer for Cartesian Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 8.64M $93.1M $10.77 Apr 11, 2025 Direct
Common Stock 657K $7.07M $10.77 Apr 11, 2025 Indirect
Common Stock 331K $3.56M $10.77 Apr 9, 2025 By wife
Stock Option (Right to Buy) 7.8K $6.16K $0.79 Jan 2, 2025 Direct Common Stock 7.6K
Series B Non-Voting Convertible Preferred Stock 0 $0 $20.00 Sep 25, 2024 By wife
Series B Non-Voting Convertible Preferred Stock 0 $0 $20.00 Sep 25, 2024 Direct
Series B Non-Voting Convertible Preferred Stock 0 $0 $20.00 Sep 25, 2024 Indirect
Warrant (Right to Buy) 114K Oct 2, 2024 Direct Common Stock
Warrant (Right to Buy) 33.4K Oct 2, 2024 Indirect Common Stock 167K
Warrant (Right to Buy) 20K Oct 2, 2024 By wife Common Stock

Transactions reported by Timothy A. Springer for Cartesian Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.